CD36-mediated hematoma absorption following intracerebral hemorrhage: Negative regulation by TLR4 signaling

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5984-5992

  Fang, Huang ^a   Chen, Jing ^a   Lin, Sen ^b   Wang, Peng Fei ^a   Wang, Yanchun ^a   Xiong, Xiao Yi ^a   Yang, Qing Wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CD36 ANTIGEN; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; RESATORVID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; HEMATOMA ABSORPTION; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; ANIMALS; ANTIGENS, CD36; BLOOD PLATELET DISORDERS; BRAIN HEMORRHAGE, TRAUMATIC; CATALASE; FEMALE; GENETIC DISEASES, INBORN; HEMATOMA, EPIDURAL, CRANIAL; HUMANS; HYDROGEN PEROXIDE; MALE; MICE, KNOCKOUT; MICROGLIA; MIDDLE AGED; MYELOID DIFFERENTIATION FACTOR 88; NERVE TISSUE PROTEINS; PHAGOCYTOSIS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84902197505     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400054     Document Type: Article

References (32)

1. Keep, R. F., Y. Hua, and G. Xi. 2012. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 11:720-731.
2. Zhao, X., G. Sun, J. Zhang, R. Strong, W. Song, N. Gonzales, J. C. Grotta, and J. Aronowski. 2007. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor γ in microglia/macrophages. Ann. Neurol. 61:352-362.
3. Zhao, X., J. Grotta, N. Gonzales, and J. Aronowski. 2009. Hematoma resolution as a therapeutic target: the role of microglia/macrophages. Stroke 40 (3, Suppl. 1):S92-S94.
4. Fang, H., P. F. Wang, Y. Zhou, Y. C. Wang, and Q. W. Yang. 2013. Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J. Neuroinflammation 10:27.
5. Nyquist, P. 2010. Management of acute intracranial and intraventricular hemorrhage. Crit. Care Med. 38:946-953.
6. Husemann, J., J. D. Loike, R. Anankov, M. Febbraio, and S. C. Silverstein. 2002. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40:195-205.
7. 3). J. Immunol. 161:6250-6257.
8. McGilvray, I. D., L. Serghides, A. Kapus, O. D. Rotstein, and K. C. Kain. 2000. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparumparasitized erythrocytes: a role for CD36 in malarial clearance. Blood 96:3231-3240.
9. Febbraio, M., D. P. Hajjar, and R. L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108:785-791.
10. Ren, Y., R. L. Silverstein, J. Allen, and J. Savill. 1995. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181:1857-1862.
11. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820.
12. Okun, E., K. J. Griffioen, and M. P. Mattson. 2011. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 34:269-281.
13. Lin, S., Q. Yin, Q. Zhong, F. L. Lv, Y. Zhou, J. Q. Li, J. Z. Wang, B. Y. Su, and Q. W. Yang. 2012. Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J. Neuroinflammation 9:46.
14. Wang, Y. C., P. F. Wang, H. Fang, J. Chen, X. Y. Xiong, and Q. W. Yang. 2013. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 44:2545-2552.
15. Zamora, C., E. Cantó, J. C. Nieto, M. Angels Ortiz, C. Juarez, and S. Vidal. 2012. Functional consequences of CD36 downregulation by TLR signals. Cytokine 60:257-265.
16. Sansing, L. H., T. H. Harris, F. A. Welsh, S. E. Kasner, C. A. Hunter, and K. Kariko. 2011. Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann. Neurol. 70:646-656.
17. Janabi, M., S. Yamashita, K. Hirano, N. Sakai, H. Hiraoka, K. Matsumoto, Z. Zhang, S. Nozaki, and Y. Matsuzawa. 2000. Oxidized LDL-induced NF-κB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler. Thromb. Vasc. Biol. 20:1953-1960.
18. Yuasa-Kawase, M., D. Masuda, T. Yamashita, R. Kawase, H. Nakaoka, M. Inagaki, K. Nakatani, K. Tsubakio-Yamamoto, T. Ohama, A. Matsuyama, et al. 2012. Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases. J. Atheroscler. Thromb. 19:263-275.
19. Kidwell, C. S., and M. Wintermark. 2008. Imaging of intracranial haemorrhage. Lancet Neurol. 7:256-267.
20. Kazui, S., H. Naritomi, H. Yamamoto, T. Sawada, and T. Yamaguchi. 1996. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 27:1783-1787.
21. Kothari, R. U., T. Brott, J. P. Broderick, W. G. Barsan, L. R. Sauerbeck, M. Zuccarello, and J. Khoury. 1996. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304-1305.
22. Lyden, P. D., A. Shuaib, K. R. Lees, A. Davalos, S. M. Davis, H. C. Diener, J. C. Grotta, T. J. Ashwood, H. G. Hardemark, H. H. Svensson, et al; CHANT Trial Investigators. 2007. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke 38:2262-2269.
23. Rać, M. E., K. Safranow, and W. Poncyljusz. 2007. Molecular basis of human CD36 gene mutations. Mol. Med. 13:288-296.
24. Kashiwagi, H., Y. Tomiyama, S. Nozaki, T. Kiyoi, S. Tadokoro, K. Matsumoto, S. Honda, S. Kosugi, Y. Kurata, and Y. Matsuzawa. 2001. Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum. Genet. 108:459-466.
25. Yang, Q. W., F. L. Lu, Y. Zhou, L. Wang, Q. Zhong, S. Lin, J. Xiang, J. C. Li, C. Q. Fang, and J. Z. Wang. 2011. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J. Cereb. Blood Flow Metab. 31:593-605.
26. Loftspring, M. C., H. L. Johnson, R. Feng, A. J. Johnson, and J. F. Clark. 2011. Unconjugated bilirubin contributes to early inflammation and edema after intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 31:1133-1142.
27. Mendelow, A. D., B. A. Gregson, E. N. Rowan, G. D. Murray, A. Gholkar, and P. M. Mitchell; STICH II Investigators. 2013. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 382:397-408.
28. Yamamoto, N., N. Akamatsu, H. Sakuraba, H. Yamazaki, and K. Tanoue. 1994. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IVon monocytes. Blood 83:392-397.
29. Aitman, T. J. 2001. CD36, insulin resistance, and coronary heart disease. Lancet 357:651-652.
30. Yamamoto, N., H. Ikeda, N. N. Tandon, J. Herman, Y. Tomiyama, T. Mitani, S. Sekiguchi, R. Lipsky, U. Kralisz, and G. A. Jamieson. 1990. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka-platelets lack detectable GPIV (CD36). Blood 76:1698-1703.
31. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. Van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, W. A. Frazier, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11:155-161.
32. Wasserman, J. K., X. Zhu, and L. C. Schlichter. 2007. Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res. 1180:140-154